Activation of p38 and NF-kB signaling pathways plays important roles in mediating the release of inflammatory mediators and antiangiogenic factors (sFlt-1, sEng and ET-1), which stimulate systemic inflammatory reactions and endothelial dysfunction that manifests PE symptoms27,34–36. This evidence concerns the gene NFKB1 and endothelial dysfunction.